doi:10.3969/j.issn.1004-583X.2024.01.018

Abstract

CLC Number:

R593.2

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2024.01.018

https://huicui.hebmu.edu.cn/EN/Y2024/V39/I1/92

References 46

[1]	Ten Klooster PM, de Graaf N, Vonkeman HE. Association between pain phenotype and disease activity in rheumatoid arthritis patients: A non-interventional, longitudinal cohort study[J]. Arthritis Res Ther, 2019, 21(1):257. doi: 10.1186/s13075-019-2042-4 pmid: 31783899
[2]	Thambiah SC, Wong TH, Gupta ED, et al. Calculation of free and bioavailable vitamin D and its association with bone mineral density in Malaysian women[J]. Malays J Pathol, 2018, 40(3):287-294. pmid: 30580359
[3]	McInnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis[J]. Lancet, 2017, 389(10086):2328-2337. doi: S0140-6736(17)31472-1 pmid: 28612747
[4]	Rydell E, Forslind K, Nilsson JÅ, et al. Predictors of radiographic erosion and joint space narrowing progression in patients with early rheumatoid arthritis: A cohort study[J]. Arthritis Res Ther, 2021, 23(1):27. doi: 10.1186/s13075-020-02413-7 pmid: 33446222
[5]	邹晋梅, 李思吟, 杨静, 等. 类风湿关节炎患者血清25-(OH)D₃水平与骨密度的关系[J]. 中国医药导报, 2019, 16(19):109-112.
[6]	Franco-Trepat E, Guillán-Fresco M, Alonso-Pérez A, et al. Visfatin connection: Present and future in osteoarthritis and osteoporosis[J]. J Clin Med, 2019, 8(8):1178. doi: 10.3390/jcm8081178 URL
[7]	Bruno D, Fedele AL, Tolusso B, et al. Systemic bone density at disease onset is associated with joint erosion progression in early naive to treatment rheumatoid arthritis: A prospective 12-month follow-up open-label study[J]. Front Med (Lausanne), 2021, 8:613889.
[8]	Mangnus L, van Steenbergen HW, Reijnierse M, et al. Bone mineral density loss in clinically suspect arthralgia is associated with subclinical inflammation and progression to clinical arthritis[J]. Scand J Rheumatol, 2017, 46(5):364-368. doi: 10.1080/03009742.2017.1299217 pmid: 28580826
[9]	鲍晓, 何成松. 糖皮质激素诱发骨质疏松的类风湿关节炎患者血清25-羟维生素D的表达与骨密度的关系[J]. 中国老年学, 2018, 38(2):429-431.
[10]	Zhu Z, Hu G, Jin F, et al. Correlation of osteoarthritis or rheumatoid arthritis with bone mineral density in adults aged 20-59 years[J]. Orthop Surg Res, 2021, 16(1):190.
[11]	Cheng TT, Lai HM, Yu SF, et al. The impact of low-dose glucocorticoids on disease activity, bone mineral density, fragility fractures, and 10-year probability of fractures in patients with rheumatoid arthritis[J]. J Investig Med, 2018, 66(6):1004-1007. doi: 10.1136/jim-2018-000723 URL
[12]	Berardi S, Corrado A, Maruotti N, et al. Osteoblast role in the pathogenesis of rheumatoid arthritis[J]. Mol Biol Rep, 2021, 48(3):2843-2852. doi: 10.1007/s11033-021-06288-y
[13]	Hecht C, Englbrecht M, Rech J, et al. Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA[J]. Ann Rheum Dis, 2015, 74(12):2151-2156. doi: 10.1136/annrheumdis-2014-205428 pmid: 25115448
[14]	Kurowska W, Slowinska I, Krogulec Z, et al. Antibodies to Citrullinated Proteins (ACPA) associate with markers of osteoclast activation and bone destruction in the bone marrow of patients with rheumatoid arthritis[J]. Clin Med, 2021, 10(8):1778.
[15]	王长磊, 孔纯玉, 戚务芳. 类风湿性关节炎患者骨代谢指标与骨密度的临床相关性研究[J]. 河北医药, 2019, 41 (18):2816-2818.
[16]	王鑫, 俞钟明, 孙佳颖. 类风湿关节炎不同疾病活动度下骨代谢指标的变化[J]. 浙江医学, 2018, 40(22):2462-2465.
[17]	Delgado-Calle J, Tu X, Pacheco-Costa R, et al. Control of bone anabolism in response to mechanical loading and PTH by distinct mechanisms downstream of the PTH receptor[J]. J Bone Miner Res, 2017, 32(3):522-535. doi: 10.1002/jbmr.3011 pmid: 27704638
[18]	Jelsness-Jørgensen LP, Grøvle L, Julsrud Haugen A. Association between vitamin D and fatigue in patients with rheumatoid arthritis: A cross-sectional study[J]. BMJ Open, 2020, 10(2):e034935. doi: 10.1136/bmjopen-2019-034935 URL
[19]	Martens PJ, Gysemans C, Verstuyf A, et al. Vitamin D's effect on immune function[J]. Nutrients, 2020, 12(5):1248. doi: 10.3390/nu12051248 URL
[20]	Di Spigna G, Del Puente A, Covelli B, et al. Vitamin D receptor polymorphisms as tool for early screening of severe bone loss in women patients with rheumatoid arthritis[J]. Eur Rev Med Pharmacol Sci, 2016, 20(22):4664-4669.
[21]	Wen HY, Luo J, Li XF, et al. 1, 25-dihydroxyvitamin D₃ modulates T cell differentiation and impacts on the production of cytokines from Chinese Han patients with early rheumatoid arthritis[J]. Immunol Res, 2019, 67(1):48-57. doi: 10.1007/s12026-018-9033-4
[22]	Testa D, Calvacchi S, Petrelli F, et al. One year in review 2021: Pathogenesis of rheumatoid arthritis[J]. Clin Exp Rheumatol, 2021, 39(3):445-452. doi: 10.55563/clinexprheumatol/j1l5l3 pmid: 34018918
[23]	Gkekas NK, Anagnostis P, Paraschou V, et al. The effect of vitamin D plus protein supplementation on sarcopenia: A systematic review and meta-analysis of randomized controlled trials[J]. Maturitas, 2021, 145:56-63. doi: 10.1016/j.maturitas.2021.01.002 pmid: 33541563
[24]	Paradowska-Gorycka A, Wajda A, Romanowska-Próchnicka K, et al. Th17/Treg-related transcriptional factor expression and cytokine profile in patients with rheumatoid arthritis[J]. Front Immunol, 2020, 11:572858. doi: 10.3389/fimmu.2020.572858 URL
[25]	Mendes MM, Charlton K, Thakur S, et al. Future perspectives in addressing the global issue of vitamin D deficiency[J]. Proc Nutr Soc, 2020, 79(2):246-251. doi: 10.1017/S0029665119001538 pmid: 32090719
[26]	Bagheri-Hosseinabadi Z, Imani D, Yousefi H, et al. Vitamin D receptor (VDR) gene polymorphism and risk of rheumatoid arthritis (RA): Systematic review and meta-analysis[J]. Clin Rheumatol, 2020, 39(12):3555-3569. doi: 10.1007/s10067-020-05143-y
[27]	Lin J, Liu J, Davies ML, et al. Serum Vitamin D level and rheumatoid arthritis disease activity: Review and meta-analysis[J]. PLoS One, 2016, 11(1):e0146351. doi: 10.1371/journal.pone.0146351 URL
[28]	Charoenngam N, Shirvani A, Kalajian TA, et al. The effect of various doses of oral vitamin D3 supplementation on gut microbiota in healthy adults: A randomized, double-blinded, dose-response study[J]. Anticancer Res, 2020, 40(1):551-556. doi: 10.21873/anticanres.13984 pmid: 31892611
[29]	Merlino LA, Curtis J, Mikuls TR, et al. Vitamin D intake is inversely associated with rheumatoid arthritis: Results from the Iowa Women's Health Study[J]. Arthritis Rheum, 2004, 50(1):72-77. doi: 10.1002/art.v50:1 URL
[30]	Meena N, Singh Chawla SP, Garg R, et al. Assessment of vitamin D in rheumatoid arthritis and its correlation with disease activity[J]. J Nat Sci Biol Med, 2018, 9(1):54-58. doi: 10.4103/jnsbm.JNSBM_128_17 URL
[31]	Aslam MM, John P, Bhatti A, et al. Vitamin D as a principal factor in mediating rheumatoid arthritis-derived immune response[J]. Biomed Res Int, 2019, 2019:3494937.
[32]	Harrison SR, Li D, Jeffery LE, et al. Vitamin D, autoimmune disease and rheumatoid arthritis[J]. Calcif Tissue Int, 2020, 106(1):58-75. doi: 10.1007/s00223-019-00577-2
[33]	Marozik P, Rudenka A, Kobets K, et al. Vitamin D status, bone mineral density, and VDR gene polymorphism in a cohort of belarusian postmenopausal women[J]. Nutrients, 2021, 13(3):837. doi: 10.3390/nu13030837 URL
[34]	Dzik KP, Kaczor JJ. Mechanisms of vitamin D on skeletal muscle function: Oxidative stress, energy metabolism and anabolic state[J]. Eur J Appl Physiol, 2019, 119(4):825-839. doi: 10.1007/s00421-019-04104-x pmid: 30830277
[35]	Wong TH, Gupta ED, Radhakrishnan AK, et al. Effects of 25-hydroxyvitamin D and vitamin D-binding protein on bone mineral density and disease activity in Malaysian patients with rheumatoid arthritis[J]. Int J Rheum Dis, 2018, 21(5):992-1000. doi: 10.1111/1756-185X.13048 pmid: 28217867
[36]	Zhao J, Xia W, Nie M, et al. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study[J]. Menopause, 2011, 18(11):1237-1243. doi: 10.1097/gme.0b013e31821d7ff7 pmid: 21747303
[37]	Kweon SM, Sohn DH, Park JH, et al. Male patients with rheumatoid arthritis have an increased risk of osteoporosis: Frequency and risk factors[J]. Medicine (Baltimore), 2018, 97(24):e11122. doi: 10.1097/MD.0000000000011122 URL
[38]	Liu YQ, Liu Y, Chen ZY, et al. Rheumatoid arthritis and osteoporosis: A bi-directional Mendelian randomization study[J]. Aging (Albany NY), 2021, 13(10):14109-14130.
[39]	Pérez-Castrillón JL, Dueñas-Laita A, Brandi ML, et al. Calcifediol is superior to cholecalciferol in improving vitamin D status in postmenopausal women: A randomized trial[J]. Bone Miner Res, 2021, 36(10):1967-1978. doi: 10.1002/jbmr.4387 URL
[40]	Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y[J]. Am J Clin Nutr, 2004, 80(3):752-758. doi: 10.1093/ajcn/80.3.752 pmid: 15321818
[41]	Hwang S, Choi HS, Kim KM, et al. Associations between serum 25-hydroxyvitamin D and bone mineral density and proximal femur geometry in Koreans: the Korean National Health and Nutrition Examination Survey (KNHANES) 2008-2009[J]. Osteoporos Int, 2015, 26(1):163-171. doi: 10.1007/s00198-014-2877-0 pmid: 25262060
[42]	Colditz J, Thiele S, Baschant U, et al. Postnatal skeletal deletion of dickkopf-1 increases bone formation and bone volume in male and female mice, despite increased sclerostin expression[J]. J Bone Miner Res, 2018, 33(9):1698-1707. doi: 10.1002/jbmr.3463 pmid: 29734465
[43]	钱鑫, 赵智明, 张蓓蓓, 等. 青藤碱对类风湿关节炎患者炎性细胞因子及免疫系统的影响[J]. 中药材, 2018, 41(5):1226-1228.
[44]	Kareem R, Botleroo RA, Bhandari R, et al. The impact of rheumatoid arthritis on bone loss: Links to osteoporosis and osteopenia[J]. Cureus, 2021, 13(8):e17519.
[45]	Adami G, Saag KG. Osteoporosis pathophysiology, epidemiology, and screening in rheumatoid arthritis[J]. Curr Rheumatol Rep, 2019, 21(7):34. doi: 10.1007/s11926-019-0836-7 pmid: 31123839
[46]	Kim JW, Jung JY, Kim HA, et al. Anti-inflammatory effects of low-dose glucocorticoids compensate for their detrimental effects on bone mineral density in patients with rheumatoid arthritis[J]. J Clin Med, 2021, 10(13):2944. doi: 10.3390/jcm10132944 URL

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 46

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Song Jialiang, Jiang Yingjie, Kong Ruina, Cai Qing, Gao Jie. IgG4-related diseases characterized by increased IgE level and eosinophil count with multiple lymphadenopathy: A case report [J]. Clinical Focus, 2024, 39(1): 57-60.
[2]	He Peihua, Zhou Xingfu, Hong Weihong, Wang Lichun, Liu Sujun, Jin Yuyan, Zeng Jiahao, Liu Lichang. Clinical analysis of 4 cases of IgG4-related kidney disease [J]. Clinical Focus, 2023, 38(11): 1016-1021.
[3]	. [J]. Clinical Focus, 2023, 38(10): 944-948.
[4]	. [J]. Clinical Focus, 2023, 38(8): 753-756.
[5]	. [J]. Clinical Focus, 2023, 38(7): 663-667.
[6]	. [J]. Clinical Focus, 2023, 38(3): 279-284.
[7]	Gao Ying, Han Zhongli, Wang Hongyan, Li Xiaofu. Magnetic resonance imaging characteristics of Andersson lesions associated with ankylosing spondylitis [J]. Clinical Focus, 2022, 37(10): 927-930.
[8]	Zhang Yueyue, Xie Meifang, Sun Gen. Rheumatoid arthritis complicated with T-cell large granular lymphocytic leukemia: A case report and literature review [J]. Clinical Focus, 2022, 37(8): 728-732.
[9]	Lin Changyi, Song Minghui, Wu Peicheng. Effects of diagnosis age on clinical manifestations of polymyalgia rheumatica: A single center retrospective cohort study on 68 patients [J]. Clinical Focus, 2022, 37(7): 612-615.
[10]	Qin Meijie, Tian Maolu, Yang Yuqi, Zha Yan, Yuan Jing. Literature review on treatment of immune thrombocytopenia secondary to refractory systemic lupus erythematosus with belimumab combined with cyclosporine: A case report and literature review [J]. Clinical Focus, 2022, 37(6): 544-547.
[11]	. [J]. Clinical Focus, 2022, 37(5): 472-476.
[12]	Hu Fangfang, Zhong Shiling, Di Yazhen, Wu Ling. Vascular endothelial function of juvenile idiopathic arthritis in pediatric patients: A systematic review and meta-analysis [J]. Clinical Focus, 2022, 37(3): 204-210.
[13]	Lin Changyi, Song Minghui, Wu Peicheng. Difference between remitting seronegative symmetrical synovitis with pitting edema syndrome and seronegative rheumatoid arthritis [J]. Clinical Focus, 2022, 37(3): 262-265.
[14]	. [J]. Clinical Focus, 2022, 37(2): 188-192.
[15]	. [J]. Clinical Focus, 2022, 37(1): 92-96.